Jere D - Search Results

1

Advancements in Understanding Immunogenicity of Biotherapeutics in the Intraocular Space.

Wakshull E, Quarmby V, Mahler HC, Rivers H, Jere D, Ramos M, Szczesny P, Bechtold-Peters K, Masli S, Gupta S. Wakshull E, et al. Among authors: jere d. AAPS J. 2017 Nov;19(6):1656-1668. doi: 10.1208/s12248-017-0128-y. Epub 2017 Aug 9. AAPS J. 2017. PMID: 28795351 Review.

2

Prediction of intraocular antibody drug stability using ex-vivo ocular model.

Patel S, Stracke JO, Altenburger U, Mahler HC, Metzger P, Shende P, Jere D. Patel S, et al. Among authors: jere d. Eur J Pharm Biopharm. 2017 Mar;112:177-186. doi: 10.1016/j.ejpb.2016.10.028. Epub 2016 Nov 16. Eur J Pharm Biopharm. 2017. PMID: 27865934

3

Evaluation of protein drug stability with vitreous humor in a novel ex-vivo intraocular model.

Patel S, Müller G, Stracke JO, Altenburger U, Mahler HC, Jere D. Patel S, et al. Among authors: jere d. Eur J Pharm Biopharm. 2015 Sep;95(Pt B):407-17. doi: 10.1016/j.ejpb.2015.04.033. Epub 2015 May 29. Eur J Pharm Biopharm. 2015. PMID: 26032291

4

Use of the permitted daily exposure (PDE) concept for contaminants of intravitreal (IVT) drugs in multipurpose manufacturing facilities.

Lovsin Barle E, Pfister T, Fux C, Röthlisberger D, Jere D, Mahler HC. Lovsin Barle E, et al. Among authors: jere d. Regul Toxicol Pharmacol. 2019 Feb;101:29-34. doi: 10.1016/j.yrtph.2018.10.007. Epub 2018 Oct 24. Regul Toxicol Pharmacol. 2019. PMID: 30367903

5

Challenges for Cell-Based Medicinal Products From a Pharmaceutical Product Perspective.

Jere D, Sediq AS, Huwyler J, Vollrath I, Kardorff M, Mahler HC. Jere D, et al. J Pharm Sci. 2021 May;110(5):1900-1908. doi: 10.1016/j.xphs.2020.11.040. Epub 2020 Dec 9. J Pharm Sci. 2021. PMID: 33307042 Review.

6

Subvisible Particulate Contamination in Cell Therapy Products-Can We Distinguish?

Vollrath I, Mathaes R, Sediq AS, Jere D, Jörg S, Huwyler J, Mahler HC. Vollrath I, et al. Among authors: jere d. J Pharm Sci. 2020 Jan;109(1):216-219. doi: 10.1016/j.xphs.2019.09.002. Epub 2019 Sep 12. J Pharm Sci. 2020. PMID: 31521641

7

Characterization of Polymeric Syringes Used for Intravitreal Injection.

Peláez SS, Mahler HC, Koulov A, Joerg S, Matter A, Vogt M, Chalus P, Zaeh M, Sediq AS, Jere D, Mathaes R. Peláez SS, et al. Among authors: jere d. J Pharm Sci. 2020 Sep;109(9):2812-2818. doi: 10.1016/j.xphs.2020.06.003. Epub 2020 Jun 11. J Pharm Sci. 2020. PMID: 32534032

8

Role of Formulation Parameters on Intravitreal Dosing Accuracy Using 1 mL Hypodermic Syringes.

Weinmann C, Sediq AS, Vogt M, Mahler HC, Joerg S, Rodriguez S, Mathaes R, Jere D. Weinmann C, et al. Among authors: jere d. Pharm Res. 2020 Sep 7;37(10):190. doi: 10.1007/s11095-020-02880-2. Pharm Res. 2020. PMID: 32895773

9

Evaluation of In Vitro Tools to Predict the In Vivo Absorption of Biopharmaceuticals Following Subcutaneous Administration.

Bender C, Eichling S, Franzen L, Herzog V, Ickenstein LM, Jere D, Nonis L, Schwach G, Stoll P, Venczel M, Zenk S. Bender C, et al. Among authors: jere d. J Pharm Sci. 2022 Sep;111(9):2514-2524. doi: 10.1016/j.xphs.2022.04.005. Epub 2022 Apr 14. J Pharm Sci. 2022. PMID: 35429492 Free article.

10

Poly (amino ester) composed of poly (ethylene glycol) and aminosilane prepared by combinatorial chemistry as a gene carrier.

Jere D, Yoo MK, Arote R, Kim TH, Cho MH, Nah JW, Choi YJ, Cho CS. Jere D, et al. Pharm Res. 2008 Apr;25(4):875-85. doi: 10.1007/s11095-007-9448-4. Epub 2007 Sep 25. Pharm Res. 2008. PMID: 17899325

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters